scholarly journals A Randomized Controlled Study of Fuzheng Huayu Capsule for Prevention of Esophageal Variceal Bleeding in Patients with Liver Cirrhosis

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Jie Gu ◽  
Qin Zhang ◽  
Dongying Xue ◽  
Hong Cai ◽  
Lieming Xu

To elucidate the role of Fuzheng Huayu Capsule, a herbal formula, in the prevention of esophageal variceal bleeding in cirrhotic patients, a multicenter randomized and placebo-controlled trial was carried out. One hundred forty-six cirrhotic patients with esophageal varices were enrolled to compare the probability of upper gastrointestinal bleeding and survival between Fuzheng Huayu Capsule group and controlled group for the duration of 2 years. The results demonstrated that the FZHYC could effectively reduce the risk of variceal bleeding and improve survival rates for cirrhotic patients with varices, especially the combination of the capsule and Propranolol, which presented a better effect; FZHYC could reduce the varices size in patients with small ones. Its effect may be related to the amelioration of hepatic fibrosis.

2013 ◽  
pp. 64-70
Author(s):  
Pham Chi Tran

Objectives: 1. To investigate the prevalence of portal hypertensive gastropathy (PHG) and the ratio of mild/severe PHG. 2. The impact of esophageal variceal ligation (EVL) combined propranolol on the progress of PHG in terms of prevalence, distribution and severity. Patients and methods: Prospective, controlled study. Cirrhotic patients with the history of esophageal variceal bleeding or acute esophageal variceal bleeding in stable condition were devided into combined group: EVL combined propranolol (study group) and propranolol only (control group). Results: Sex ratio Male/Female: 82/4 = 20.5. Majority of cirrhotic etiology was alcohol: 73.3%. Esophageal varices grade II and III, no grade I. Prevalence of PHG: 90.7%, ratio of mild/ severe PHG: 12.8%/87.2%. The ratio, distribution and severity of PHG between the study group and control group after 3 and 6 months were not significantly different. Conclusions: 1. The prevalence of PHG: 90.7%, the ratio of mild/severe PHG: 12.8%/87.2%. 2. EVL combined propranolol did not change significantly the prevalence, distribution and severity ofPHG in comparison with propranolol group. Key words: Cirrhosis, portal hypertensive gastropathy, esophageal variceal ligation, propranolol.


1992 ◽  
Vol 16 (3) ◽  
pp. 320-325 ◽  
Author(s):  
Shinn-Jang Hwang ◽  
Han-Chieh Lin ◽  
Chia-Fu Chang ◽  
Fa-Yauh Lee ◽  
Chi-Wen Lu ◽  
...  

2014 ◽  
Vol 13 (3) ◽  
pp. 364-369 ◽  
Author(s):  
Zuo-Hua Gan ◽  
Chen-Chi Tsai ◽  
Kuo-Chih Tseng ◽  
Chih-Chun Tsai ◽  
Yu-Hsi Hsieh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document